Literature DB >> 28932531

Adverse events with bioresorbable vascular scaffolds in routine percutaneous coronary interventions: "coup de théâtre" or unfinished play?

Salvatore Cassese1, Oliver Husser1, Adnan Kastrati1,2.   

Abstract

Year:  2017        PMID： 28932531      PMCID： PMC5594123          DOI： 10.21037/jtd.2017.07.74

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  24 in total

1.  Prolonged dual antiplatelet therapy after drug-eluting stenting: meta-analysis of randomized trials.

Authors:  Salvatore Cassese; Robert A Byrne; Gjin Ndrepepa; Heribert Schunkert; Massimiliano Fusaro; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2015-04-23       Impact factor: 5.460

Review 2.  Bioresorbable Scaffold: The Emerging Reality and Future Directions.

Authors:  Yohei Sotomi; Yoshinobu Onuma; Carlos Collet; Erhan Tenekecioglu; Renu Virmani; Neal S Kleiman; Patrick W Serruys
Journal:  Circ Res       Date:  2017-04-14       Impact factor: 17.367

Review 3.  Midterm Safety and Efficacy of ABSORB Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent: An Updated Meta-Analysis.

Authors:  Francis J Ha; Nitesh Nerlekar; James D Cameron; Martin R Bennett; Ian T Meredith; Nick E J West; Adam J Brown
Journal:  JACC Cardiovasc Interv       Date:  2017-02-13       Impact factor: 11.195

4.  Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score.

Authors:  Luis Ortega-Paz; Davide Capodanno; Tommaso Gori; Holger Nef; Azeem Latib; Giuseppe Caramanno; Carlo Di Mario; Christoph Naber; Maciej Lesiak; Piera Capranzano; Jens Wiebe; Julinda Mehilli; Aleksander Araszkiewicz; Stelios Pyxaras; Alessio Mattesini; Salvatore Geraci; Toru Naganuma; Antonio Colombo; Thomas Münzel; Manel Sabaté; Corrado Tamburino; Salvatore Brugaletta
Journal:  EuroIntervention       Date:  2017-04-20       Impact factor: 6.534

Review 5.  Very Late Scaffold Thrombosis of Bioresorbable Vascular Scaffold: Systematic Review and a Meta-Analysis.

Authors:  Toshiaki Toyota; Takeshi Morimoto; Hiroki Shiomi; Yusuke Yoshikawa; Hidenori Yaku; Yugo Yamashita; Takeshi Kimura
Journal:  JACC Cardiovasc Interv       Date:  2017-01-09       Impact factor: 11.195

Review 6.  Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis.

Authors:  Ramez Nairooz; Marwan Saad; Partha Sardar; Wilbert S Aronow
Journal:  Heart       Date:  2017-01-23       Impact factor: 5.994

7.  Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: rationale and study design.

Authors:  Pier Woudstra; Maik J Grundeken; Robin P Kraak; Mariëlla E C J Hassell; E Karin Arkenbout; Jan Baan; Marije M Vis; Karel T Koch; Jan G P Tijssen; Jan J Piek; Robbert J de Winter; José P S Henriques; Joanna J Wykrzykowska
Journal:  Am Heart J       Date:  2013-10-17       Impact factor: 4.749

Review 8.  Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.

Authors:  Salvatore Cassese; Robert A Byrne; Gjin Ndrepepa; Sebastian Kufner; Jens Wiebe; Janika Repp; Heribert Schunkert; Massimiliano Fusaro; Takeshi Kimura; Adnan Kastrati
Journal:  Lancet       Date:  2015-11-17       Impact factor: 79.321

9.  Mid-term and long-term safety and efficacy of bioresorbable vascular scaffolds versus metallic everolimus-eluting stents in coronary artery disease: A weighted meta-analysis of seven randomised controlled trials including 5577 patients.

Authors:  J Elias; I M van Dongen; R P Kraak; R Y G Tijssen; B E P M Claessen; J G P Tijssen; R J de Winter; J J Piek; J J Wykrzykowska; J P S Henriques
Journal:  Neth Heart J       Date:  2017-07       Impact factor: 2.380

Review 10.  Late thrombotic events after bioresorbable scaffold implantation: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Carlos Collet; Taku Asano; Yosuke Miyazaki; Erhan Tenekecioglu; Yuki Katagiri; Yohei Sotomi; Rafael Cavalcante; Robbert J de Winter; Takeshi Kimura; Runlin Gao; Serban Puricel; Stéphane Cook; Davide Capodanno; Yoshinobu Onuma; Patrick W Serruys
Journal:  Eur Heart J       Date:  2017-09-01       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.